Nosopharm raised €2.4M in a Early VC round in Nov 2020. The company is based in Nimes, France. Investors in the round: Alto Invest, Auriga Partners, Kreaxi. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €2.4M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
